MX2016011903A - Un procedimiento para la preparacion de (2s, 5r) -6- (benciloxi) -7-oxo-1,6-diazabiciclo [3.2.1] octan-2-carboxilato de sodio. - Google Patents
Un procedimiento para la preparacion de (2s, 5r) -6- (benciloxi) -7-oxo-1,6-diazabiciclo [3.2.1] octan-2-carboxilato de sodio.Info
- Publication number
- MX2016011903A MX2016011903A MX2016011903A MX2016011903A MX2016011903A MX 2016011903 A MX2016011903 A MX 2016011903A MX 2016011903 A MX2016011903 A MX 2016011903A MX 2016011903 A MX2016011903 A MX 2016011903A MX 2016011903 A MX2016011903 A MX 2016011903A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- diazabicyclo
- benzyloxy
- octane
- carboxylate
- Prior art date
Links
- WMJQXLGGFODMFW-LYCTWNKOSA-M sodium;(2s,5r)-7-oxo-6-phenylmethoxy-1,6-diazabicyclo[3.2.1]octane-2-carboxylate Chemical compound [Na+].C([C@H]1CC[C@H]2C(=O)[O-])N2C(=O)N1OCC1=CC=CC=C1 WMJQXLGGFODMFW-LYCTWNKOSA-M 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN858MU2014 IN2014MU00858A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2014-03-14 | 2015-03-12 | |
| PCT/IB2015/051794 WO2015136473A1 (en) | 2014-03-14 | 2015-03-12 | A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016011903A true MX2016011903A (es) | 2016-12-05 |
Family
ID=53005597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016011903A MX2016011903A (es) | 2014-03-14 | 2015-03-12 | Un procedimiento para la preparacion de (2s, 5r) -6- (benciloxi) -7-oxo-1,6-diazabiciclo [3.2.1] octan-2-carboxilato de sodio. |
Country Status (8)
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008326381B2 (en) | 2007-11-21 | 2014-10-23 | Decode Genetics Ehf | Biaryl PDE4 inhibitors for treating inflammation |
| WO2010126820A2 (en) | 2009-04-30 | 2010-11-04 | Merck Sharp & Dohme Corp. | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids |
| US8772490B2 (en) * | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
| KR102143660B1 (ko) * | 2011-06-17 | 2020-08-11 | 화이자 안티-인펙티브스 에이비 | 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법 |
| CA2869051A1 (en) * | 2012-03-30 | 2013-10-03 | Cubist Pharmaceuticals, Inc. | Isoxazole .beta.-lactamase inhibitors |
| NZ711343A (en) | 2013-03-08 | 2016-07-29 | Wockhardt Ltd | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation |
| AU2014333436A1 (en) | 2013-10-11 | 2016-05-05 | Wockhardt Limited | Nitrogen containing compounds and their use |
-
2015
- 2015-03-12 WO PCT/IB2015/051794 patent/WO2015136473A1/en active Application Filing
- 2015-03-12 EP EP15718590.1A patent/EP3116875A1/en not_active Withdrawn
- 2015-03-12 US US15/125,554 patent/US9790223B2/en not_active Expired - Fee Related
- 2015-03-12 CN CN201580014017.5A patent/CN106458896A/zh active Pending
- 2015-03-12 IN IN858MU2014 patent/IN2014MU00858A/en unknown
- 2015-03-12 KR KR1020167026620A patent/KR20160132414A/ko not_active Withdrawn
- 2015-03-12 MX MX2016011903A patent/MX2016011903A/es unknown
- 2015-03-12 JP JP2016574517A patent/JP2017513926A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3116875A1 (en) | 2017-01-18 |
| US9790223B2 (en) | 2017-10-17 |
| IN2014MU00858A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-09-25 |
| KR20160132414A (ko) | 2016-11-18 |
| JP2017513926A (ja) | 2017-06-01 |
| CN106458896A (zh) | 2017-02-22 |
| US20170008892A1 (en) | 2017-01-12 |
| WO2015136473A1 (en) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501340A1 (en) | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives | |
| NZ711326A (en) | A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane | |
| PH12017501016B1 (en) | Triazolopyrimidine compounds and uses thereof | |
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| PH12016500169A1 (en) | Polymorph of syk inhibitors | |
| NZ711343A (en) | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation | |
| MX2016012648A (es) | Proceso para la preparacion de (2s,5r)-6-(benciloxi)-7-oxo-1,6-dia zabiciclo[3.2.1]octano-2-carboxilato de sodio. | |
| EP3008069A4 (en) | PREPARATION OF TERT-BUTYL-4 - ((1R, 2S, 5R) -6- (BENZYLOXY) -7-OXO-1,6-DIAZABICYCLO [3.2.1] OCTAN-2-CARBOXAMIDO) PIPERIDINE-1-CARBOXYLATE | |
| IN2014MU00195A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| SG10201901578UA (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| IN2013MU00916A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| NZ711328A (en) | A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane | |
| MX2016011903A (es) | Un procedimiento para la preparacion de (2s, 5r) -6- (benciloxi) -7-oxo-1,6-diazabiciclo [3.2.1] octan-2-carboxilato de sodio. | |
| IN2014MU00194A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| IN2014MU01196A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| TN2017000065A1 (en) | A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor | |
| MX2014012822A (es) | Proceso para elaborar derivados de naftiridina. | |
| IN2013MU01219A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| MX2019000984A (es) | Proceso para preparacion de indanonas. | |
| IN2013MU03670A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| IN2013MU00777A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| IN2014MU01195A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| MX2017010192A (es) | Proceso de produccion de ciclo-deshidrolinalool (i). | |
| MX365384B (es) | Metodo de sintesis de derivados de 9-alilcamptotecina. | |
| IN2014MU00070A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |